Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…
REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…
SHANGHAI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
DUBAI, UAE, Sept. 29, 2025 /PRNewswire/ -- Bybit Limited (Bybit Kazakhstan), a crypto exchange licensed by the Astana Financial Services…
Over 130 genes and 150 traits analysed to provide personalised skin careGeneIQ – India's first medico-aesthetic clinic application reinforces our…
MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative…
SCOTTSDALE, Ariz., Sept. 10, 2025 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in Imaging CRO technologies and services for…
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from…
Report highlights DXC's strengths leveraging GenAI platforms, equipping software engineers with secure AI-powered assets and services to accelerate software development.…
ISTANBUL, Aug. 7, 2025 /PRNewswire/ -- KuCoin, a leading global cryptocurrency exchange, is pleased to announce that its Türkiye collaborative…